Brintellix 5 mg, 10 mg, 15 mg and 20 mg FC tablets

Brintellix 5 mg, 10 mg, 15 mg and 20 mg FC tablets

S5
PDF Leaflet Revision Date: January 2024

API: Vortioxetine | Company: H Lundbeck

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of major depressive disorder and relapse prevention.

Dosage (summary)

Starting dose 10 mg once daily, may adjust 5-20 mg based on response.

Special Populations

  • Elderly patients
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Not recommended during pregnancy or breastfeeding.

Key Drug Interactions

  • MAOIs
  • CYP2D6 inhibitors
  • Serotonergic medicines

Contraindications

  • Hypersensitivity to vortioxetine
  • Concomitant use with MAOIs

Common side effects

  • Nausea
  • Dizziness
  • Headache
  • Diarrhoea

Counselling Points

  • Monitor for suicidal behavior
  • Avoid abrupt discontinuation
  • Caution with driving due to dizziness

Serious warnings

  • Risk of suicidal thoughts
  • Serotonin syndrome
  • Seizures
Important Disclaimer

The Brintellix 5 mg, 10 mg, 15 mg and 20 mg FC tablets professional information leaflet below is the property of H Lundbeck and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites